MO offered us a trial of olaparib in combination with AZD6738 . Husband did not have braca or any other gene mutations show up on DNA testing so I asked why we would go on this. He said "if it works, it will help bone mets" . It is a phase two trial to check efficacy in patients without gene mutations the theory behind this is the new drug will activate the olaparib into working on genes without mutations so that is what they are testing for . Still mulling this over but feel that we are in a position where psa and alkaline phosphates are both rising (84/169) and scans show progression in spine, pelvis and ribs, I'm leaning toward not jumping into this trial but getting RA 223 started soon. A request for referral to nuclear medicine was put in by our MO and hopefully we will meet with them soon. Also again discussing getting tissue sample for any trials going forward including for a PSMA scan. Also discussed out of pocket PSMA scan to think about LU 177 in the future. I
Thoughts?